CRISPR Gene Editing: A New Era in Precision Medicine
CRISPR gene editing has evolved from a naturally occurring bacterial immune mechanism into one of the most influential technologies...
Early-Life Antibiotic Exposure, Gut Microbiome, and Neurodevelopment
Over the past few decades, there has been a dramatic increase in the incidence of childhood neurodevelopmental disorders such...
Potential New Targets to Treat Acute Myeloid Leukemia
Researchers have discovered new therapeutic targets for acute myeloid leukemia (AML). A new study published in Stem Cells suggests...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...